CRBP - Corbus gains ahead of Goldman Sachs event
2024-06-11 15:42:39 ET
More on Corbus Pharmaceuticals
- Corbus: Nectin-4 Targeting Proven With U.S. Data On The Way Early 2025
- Neutral On Corbus Pharmaceuticals' Financials And Clinical Progress In Oncology
- Corbus outlines phase 1 results from ADC trial for bladder, cervical cancers
- Corbus Pharmaceuticals a new outperform at RBC on cancer, obesity assets
- Seeking Alpha’s Quant Rating on Corbus Pharmaceuticals